Invizyne Technologies' (NASDAQ:IZTC - Get Free Report) lock-up period will end on Monday, May 12th. Invizyne Technologies had issued 1,875,000 shares in its IPO on November 13th. The total size of the offering was $15,000,000 based on an initial share price of $8.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.
Invizyne Technologies Stock Performance
Shares of IZTC opened at $10.89 on Monday. The firm's fifty day moving average is $12.85. Invizyne Technologies has a 1-year low of $8.50 and a 1-year high of $23.00.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. BNP Paribas Financial Markets purchased a new stake in Invizyne Technologies in the fourth quarter valued at approximately $35,000. Geode Capital Management LLC purchased a new stake in shares of Invizyne Technologies in the 4th quarter valued at $277,000. Finally, Citadel Advisors LLC acquired a new stake in shares of Invizyne Technologies in the fourth quarter worth $456,000.
Invizyne Technologies Company Profile
(
Get Free Report)
Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Invizyne Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invizyne Technologies wasn't on the list.
While Invizyne Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.